NCT00268749已完成2 期
Glycine Treatment of Prodromal Symptoms
适应症
干预措施
相关药物
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 入组人数
- 10
- 主要终点
- Scale Of Prodromal Symptoms total score
研究概览
简要总结
This is an open label trial of the NMDA agonist glycine used alone for symptoms that appear to be prodromal for schizophrenia in adolescents and young adults.
研究设计
- 研究类型
- Interventional
- 分配方式
- Na
- 干预模型
- Single Group
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 14 Years 至 35 Years（Child, Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •age 14-35
- •meets SIPS criteria for psychosis prodrome
排除标准
- •current antipsychotic medication
- •more than 4 weeks of antipsychotic medication lifetime
研究组 & 干预措施
1
Experimental
干预措施: glycine (Drug)
结局指标
主要结局
Scale Of Prodromal Symptoms total score
时间窗: 8 weeks
次要结局
未报告次要终点
研究者
相似试验
已完成
2 期
Facilitation of NMDA Receptor Function in Patients With Schizophrenia and Co-morbid AlcoholismSchizophreniaAlcoholismNCT00338598Yale University20
终止
1 期
Study of the Effects of Glycine on Symptoms and Memory in Patients With SchizophreniaSchizophreniaSchizoaffective DisorderNCT00575848North Suffolk Mental Health Association16
已完成
2 期
Effectiveness of GW468816, an NMDA Glycine Site Antagonist, for Prevention of Relapse to SmokingNicotine DependenceNCT00218465Massachusetts General Hospital264
已完成
1 期
Efficacy Study of GLYC-101 to Evaluate Outcomes After Post-laser AblationWoundsNCT00656474TR Therapeutics12
终止
不适用
Glycine Supplement for Severe COVID-19COVID-19SARS-CoV InfectionSARS (Severe Acute Respiratory Syndrome)SARS PneumoniaARDS, HumanPneumonia, ViralNCT04443673Instituto Nacional de Enfermedades Respiratorias59